In these videos, Douglas H. Jones, MD, the medical director and CEO of Global Allergy Immune Network, discusses the latest developments in the treatment and of hereditary angioedema.

In these videos, Douglas H. Jones, MD, the medical director and CEO of Global Allergy Immune Network, discusses the latest developments in the treatment and of hereditary angioedema.

In these videos, Douglas H. Jones, MD, the medical director and CEO of Global Allergy Immune Network, discusses the latest developments in the treatment and of hereditary angioedema.

In these videos, Douglas H. Jones, MD, the medical director and CEO of Global Allergy Immune Network, discusses the latest developments in the treatment and of hereditary angioedema.

In these videos, Douglas H. Jones, MD, the medical director and CEO of Global Allergy Immune Network, discusses the latest developments in the treatment and of hereditary angioedema.

Older adults who developed incident HF showed acute declines in cognition, memory and executive function, followed by a steep ...

The burnout contagion continues to rage on, with no end in sight.Although we may see glimpses of positive reforms proposed to ...

At this year’s AIMed25 conference, attendees will learn more about the future of AI in health care from industry leaders, ...

Thousands of health care providers will attend this year’s Osteopathic Medical Education Conference, or OMED, taking place in ...

In this video from the American Society of Retina Specialists annual meeting, Arshad M. Khanani, MD, MA, FASRS, presents 3.5-year results from the TRUCKEE study.The study investigated the efficacy, ...

In this video, Suzanne E. Schindler, MD, PhD, discusses her presentation from the Alzheimer’s Association International Conference on the accuracy of blood-based biomarkers in identifying those at ...

Among pediatric patients with acute respiratory distress syndrome, the likelihood for a shorter weaning was elevated when ventilation was managed by a computerized decision support tool, according to ...